|
[1]GAFFNEY DK.Radiation oncology:imaging and treatment[M].Altona, Manitoba, Canada:AMIRSYS, 2013:5-128.
|
|
[2]SPALDING D, WILLIAMSON RCN.Pancreatic cancer[J].Medicine (Baltimore) , 2011, 39:274-278.
|
|
[3]IEGEL R, NAISHADHAM D, JEMAL A.Cancer statistics[J].CA Cancer J Clin, 2013, 63:11-30.
|
|
[4]CHEN WQ, ZENG HM, ZHENG RS, et al.Cancer incidence and mortality in China[J].Chin J Caner Res, 2007, 24:1-8.
|
|
[5]BILIMORIA KY, BENTREM DJ, KO CY, et al.Validation of the6th edition AJCC Pancreatic Cancer Staging System:report from the National Cancer Database[J].Cancer, 2007, 110 (4) :738-744.
|
|
[6]TRAN KT, SMEENK HG, van EIJCK CH, et al.Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure:a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors[J].Ann Surg, 2004, 240 (5) :738-745.
|
|
[7]SEILER CA, WAGNER M, BACHMANN T, et al.Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results[J].Br J Surg, 2005, 92 (5) :547-556.
|
|
[8]LIN PW, SHAN YS, LIN YJ, et al.Pancreaticoduodenectomy for pancreatic head cancer:PPPD versus Whipple procedure[J].Hepatogastroenterology, 2005, 52 (65) :1601-1604.
|
|
[9]IQBAL N, LOVEGROVE RE, TILNEY HS, et al.A comparison of pancreaticoduodenectomy with pylorus preserving pancreaticoduodenectomy:a meta-analysis of 2822 patients[J].Eur J Surg Oncol, 2008, 34 (11) :1237-1245.
|
|
[10]YEO CJ, CAMERON JL, SOHN TA, et al.Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma:comparison of morbidity and mortality and short-term outcome[J].Ann Surg, 1999, 229 (5) :613-622.
|
|
[11]HAZARD L, TWARD JD, SZABO A, et al.Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma:results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data[J].Cancer, 2007, 110 (10) :2191-2201.
|
|
[12]OETTLE H, POST S, NEUHAUS P, et al.Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer:a randomized controlled trial[J].JAMA, 2007, 297 (3) :267-277.
|
|
[13]POTOSKY AL, DAVIS WW, HOFFMAN RM, et al.Five-year outcomes after prostatectomy or radiotherapy for prostate cancer:the prostate cancer outcomes study[J].J Natl Cancer Inst, 2004, 96 (18) :1358-1367.
|
|
[14]PEETERS ST, HEEMSBERGEN WD, KOPER PC, et al.Dose-response in radiotherapy for localized prostate cancer:results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy[J].J Clin Oncol, 2006, 24 (13) :1990-1996.
|
|
[15]KUBAN DA, TUCKER SL, DONG L, et al.Long-term results of the M.D.Anderson randomized dose-escalation trial for prostate cancer[J].Int J Radiat Oncol Biol Phys, 2008, 70 (1) :67-74.
|
|
[16]MA J, MAI HQ, HONG MH, et al.Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma[J].J Clin Oncol, 2001, 19 (5) :1350-1357.
|
|
[17]KAM MK, LEUNG SF, ZEE B, et al.Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients[J].J Clin Oncol, 2007, 25 (31) :4873-4879.
|
|
[18]GRILLS IS, MANGONA VS, WELSH R, et al.Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer[J].J Clin Oncol, 2010, 28 (6) :928-935.
|
|
[19]LI Y, YAN Y, TIAN QH, et al.3-dimensional conformal radiation therapy plus arterial infusion chemotherapy for locally advanced pancreatic cancer[J].Chin J Radial Oncol, 2002, 11 (1) :15-17. (in Chinese) 李玉, 闫英, 田启和, 等.三维适形放射治疗加动脉化疗胰腺癌的疗效分析[J].中华放射肿瘤学杂志, 2002, 11 (1) :15-17.
|
|
[20]XIA TY, SUN QX, YU Y, et al.Analysis of clinical outcomes of body gamma knife therapy for 52 patients with advanced pancreatic cardnoma[J].Chin J Hepatobiliary Surg, 2006, 12 (2) :86-88. (in Chinese) 夏廷毅, 孙庆选, 于涌, 等.体部γ-刀治疗52例胰腺癌的疗效分析[J].中华肝胆外科杂志, 2006, 12 (2) :86-88.
|
|
[21]ZHOU GX, CHEN GX, CUI SX, et al.Treatment of pancreatic cancer with stereotactic radiotherapy in combination with external irradiation[J].Chin J Hepatobiliary Surg, 2001, 7 (7) :415-417. (in Chinese) 周桂霞, 陈国雄, 崔书祥, 等.体部立体定向适形放射治疗胰腺癌的临床初探[J].中华肝胆外科杂志, 2001, 7 (7) :415-417.
|
|
[22]YU JM, YU YH, YIN Y, et al.Stereotactic radio therapy for pancreatic head carcinoma:an analysis of 13 cases[J].Chin J Radiat Oncol, 2001, 10 (2) :125. (in Chinese) 于金明, 于甬华, 尹勇, 等.X射线立体定向放射治疗胰头癌13例分析[J].中华放射肿瘤学杂志, 2001, 10 (2) :125.
|
|
[23]CHANG DS, XIA TY, LI P, et al.Clinical outcome of whole bodyγ-knife for limited pancreatic carcinoma[J].Chin J Radial Oncol, 2009, 18 (6) :470-473. (in Chinese) 常冬姝, 夏廷毅, 李平, 等.全身γ刀治疗局限期胰腺癌临床结果分析[J].中华放射肿瘤学杂志, 2009, 18 (6) :470-473.
|
|
[24]WANG J, XIA TY, WANG YJ, et al.Long-term results of gamma ray-based stereotacitc body radiation therapy in treatment of medically unfit or inoperable non-metastatic pancreatic adenocarcinoma[J].Int J Radiat Oncol Biol Phys, 2012, 84:s815-816.
|
|
[25]LI G, YU YY, HAN C, et al.Efficacy analysis of three-dimensional conformal radiotherapy with increasing dose in late course in81 cases of pancreatic cancer patients[J].J China Med Univ, 2012, 41 (12) :1134-1143. (in Chinese) 李光, 于洋洋, 韩冲, 等.81例胰腺癌后程加量三维适形放疗的疗效分析[J].中国医科大学学报, 2012, 41 (12) :1134-1143.
|
|
[26]CHANG D, XIA T, LI P, et al.Promising clinical outcome of stereotactic body radiation therapy for limited pancreatic carcinoma[J].Int J Radiat Oncol Biol Phys, 2010, 78:s307.
|
|
[27]XIA T, SUN QX, LI HQ, et al.Clinical outcomes of whole body gamma knife therapy for 52 patients with advanced pancreatic carcinoma[J].Int J Radiat Oncol Biol Phys, 2006, 66:s298-s299.
|
|
[28]IKEDA M, IOKA T, ITO Y, et al.A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer[J].Int J Radiat Oncol Biol Phys, 2013, 85 (1) :163-169.
|
|
[29]BLACKSTOCK AW, TEPPER JE, Niedwiecki D, et al.Cancer and leukemia group B (CALGB) 89805:phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas[J].Int J Gastrointest Cancer, 2003, 34 (2-3) :107-116.
|
|
[30]HUGUET F, GIRARD N, GUERCHE CS, et al.Chemoradiotherapy in the management of locally advanced pancreatic carcinoma:a qualitative systematic review[J].J Clin Oncol, 2009, 27 (13) :2269-2277.
|
|
[31]KRISHNAN S, RANA V, JANJAN NA, et al.Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy[J].Cancer, 2007, 110 (1) :47-55.
|
|
[32]LOEHRER PJ Sr., FENG Y, CARDENES H, et al.Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer:an Eastern Cooperative Oncology Group trial[J].J Clin Oncol, 2011, 29 (31) :4105-4112.
|
|
[33]MURPHY JD, ADUSUMILLI S, GRIFFITH KA, et al.Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer[J].Int J Radiat Oncol Biol Phys, 2007, 68 (3) :801-808.
|
|
[34]WILKOWSKI R, THOMA M, WEINGANDT H, et al.Chemoradiation for ductal pancreatic carcinoma:principles of combining chemotherapy with radiation, definition of target volume and radiation dose[J].Jop, 2005, 6 (3) :216-230.
|
|
[35]JINGU K, TANABE T, NEMOTO K, et al.Intraoperative radiotherapy for pancreatic cancer:30-year experience in a single institution in Japan[J].Int J Radiat Oncol Biol Phys, 2012, 83 (4) :e507-e511.
|
|
[36]CRANE CH, BEDDAR AS, EVANS DB.The role of intraoperative radiotherapy in pancreatic cancer[J].Surg Oncol Clin N Am, 2003, 12 (4) :965-977.
|
|
[37]MAXIMOUS DW, ABDEL-WANIS ME, EL-SAYED MI, et al.Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma[J].Int Arch Med, 2009, 2 (1) :7.
|
|
[38]CHUONG MD, SPRINGETT GM, FREILICH JM, et al.Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated[J].Int J Radiat Oncol Biol Phys, 2013, 86 (3) :516-522.
|
|
[39]WHITE RR, HURWITZ HI, MORSE MA, et al.Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas[J].Ann Surg Oncol, 2001, 8 (10) :758-765.
|
|
[40]LE SCODAN R, MORNEX F, GIRARD N, et al.Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma:feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review[J].Ann Oncol, 2009, 20 (8) :1387-1396.
|
|
[41]EVANS DB, VARADHACHARY GR, CRANE CH, et al.Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head[J].J Clin Oncol, 2008, 26 (21) :3496-3502.
|
|
[42]VARADHACHARY GR, WOLFF RA, CRANE CH, et al.Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head[J].J Clin Oncol, 2008, 26 (21) :3487-3495.
|
|
[43]STOCKEN DD, BUCHLER MW, DERVENIS C, et al.Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer[J].Br J Cancer, 2005, 92 (8) :1372-1381.
|
|
[44]KLEEFF J, MICHALSKI CW, FRIESS H, et al.Surgical treatment of pancreatic cancer:the role of adjuvant and multimodal therapies[J].Eur J Surg Oncol, 2007, 33 (7) :817-823.
|
|
[45]NEOPTOLEMOS JP, DUNN JA, STOCKEN DD, et al.Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer:a randomised controlled trial[J].Lancet, 2001, 358 (9293) :1576-1585.
|
|
[46]Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer.Gastrointestinal Tumor Study Group[J].Cancer, 1987, 59 (12) :2006-2010.
|
|
[47]REGINE WF, WINTER KA, ABRAMS RA, et al.Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma:a randomized controlled trial[J].JAMA, 2008, 299 (9) :1019-1026.
|
|
[48]van LAETHEM JL, HAMMEL P, MORNEX F, et al.Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer:a randomized EORTC-40013-22012/FFCD-9203/G*ERCOR phase II study[J].J Clin Oncol, 2010, 28 (29) :4450-4456.
|
|
[49]HERMAN JM, SWARTZ MJ, HSU CC, et al.Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas:results of a large, prospectively collected database at the Johns Hopkins Hospital[J].J Clin Oncol, 2008, 26 (21) :3503-1350.
|
|
[50]SMEENK HG, van EIJCK CH, HOP WC, et al.Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation:long-term results of EORTC trial 40891[J].Ann Surg, 2007, 246 (5) :734-740.
|
|
[51]REGINE WF, WINTER KA, ABRAMS R, et al.Fluorouracilbased chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma:5-year analysis of the U.S.Intergroup/RTOG 9704 phase III trial[J].Ann Surg Oncol, 2011, 18 (5) :1319-1326.
|
|
[52]ZIMMERMANN FB, JEREMIC B, LERSCH C, et al.Dose escalation of concurrent hypofractionated radiotherapy and continuous infusion 5-FU-chemotherapy in advanced adenocarcinoma of the pancreas[J].Hepatogastroenterology, 2005, 52 (61) :246-250.
|
DownLoad: